Semi-Automation

Delivered Dose Uniformity (DDU)

Our range of Delivered Dose Uniformity (DDU) sampling apparatus are designed to help accurately assess the total amount of emitted drug.

Aerodynamic Particle Size Distribution (APSD)

Our range of precision engineered cascade impactors measure the size distribution (particle size) of inhaled drug products, providing critical information about where particles in aerosol clouds are likely to be deposited in the lungs following inhalation.

Ancillaries

Optimise inhaler testing workflows with our broad range of supporting equipment required to make up fully-operating test systems for Delivered Dose Uniformity (DDU) and Aerodynamic Particle Size Distribution (APSD) of orally inhaled and nasal drug products (OINDPs).

Special Applications

Copley Scientific offers a range of testing equipment for additional qualification and validation of orally inhaled and nasal drug products (OINDPs), including assessments of generic drug formulations, inhaled dissolution testing and improving IVIVCs.

Improving IVIVCs

Better in vitro – in vivo correlation (IVIVC) has long been an industry aim. This is particularly difficult in the case of inhaled and nasal products because of the complications involved in precisely correlating drug deposition behaviour with clinical efficacy, the impact of patient-to-patient variability and the complex interaction between formulation and device. One strategy for improving the significance of cascade impaction data is to modify the test set-up in order to mimic the in vivo d

Inhalytix®

Inhalytix® – Our fully compliant data analysis software offers analysts a flexible and validated solution for the analysis and reporting of the aerodynamic particle size distribution (APSD) drug output from all OINDPs.